A Trial Testing SP-420 in Subjects With Transfusion-dependent β-thalassemia
Status:
Not yet recruiting
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to learn about SP-420 ability to remove iron from organs
in subjects with transfusion-dependent β-thalassemia. The main questions it aims to answer
are:
- How efficient is SP-420 in cleaning iron from the liver?
- How is the safety and tolerability of ascending doses of SP-420?
Participants will:
- Take medication three time weekly
- Attend up to 20 site visits
- Undergo MRI scans